Abstract:Background Polo-like kinase 1 (PLK1) is highly expressed in many human cancers and regulates critical steps in mitotic progression. Previously, we have reported that PLK1 was overexpressed in non-small cell lung cancer (NSCLC), but the underlying molecular mechanisms are not well understood. By using microRNA (miR) target prediction algorithms, we identified miR-100 that might potentially bind the 3’-untranslated region of PLK1 transcripts. The purpose of this study was to investigate the roles of miR-100 and its association with PLK1 in NSCLC development. Methods Taqman real-time quantitative RT-PCR assay was performed to detect miR-100 expression 10 NSCLC tissues and corresponding nontumor tissues. Additionally, the expression of miR-100 in 110 NSCLC tissues and its correlation with clinicopathological factors or prognosis of patients was analyzed. Finally, the effects of miR-100 expression on growth, apoptosis and cell cycle of NSCLC cells by posttranscriptionally regulating PLK1 expression were determined. Results MiR-100 was significantly downregulated in NSCLC tissues, and low miR-100 expression was found to be closely correlated with higher clinical stage, advanced tumor classification and lymph node metastasis of patients. The overall survival of NSCLC patients with low miR-100 was significantly lower than that of those patients with high miR-100, and univariate and multivariate analyses indicated that low miR-100 expression might be a poor prognostic factor. Also, miR-100 mimics could lead to growth inhibition, G 2 /M cell cycle arrest and apoptosis enhancement in NSCLC cells. Meanwhile, miR-100 mimics could significantly inhibit PLK1 mRNA and protein expression and reduce the luciferase activity of a PLK1 3’ untranslated region-based reporter construct in A549 cells. Furthermore, small interfering RNA (siRNA)-mediated PLK1 downregulation could mimic the effects of miR-100 mimics while PLK1 overexpression could partially rescue the phenotypical changes of NSCLC cells induced by miR-100 mimics. Conclusions Our findings indicate that low miR-100 may be a poor prognostic factor for NSCLC patients and functions as a tumor suppressor by posttranscriptionally regulating PLK1 expression.

MicroRNA-100 is a Potential Molecular Marker of Non-Small Cell Lung Cancer and Functions As a Tumor Suppressor by Targeting Polo-Like Kinase 1

Reduced Mir-100 Expression in Cervical Cancer and Precursors and Its Carcinogenic Effect Through Targeting PLK1 Protein.

miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Mir-593-5p Inhibit Cell Proliferation by Targeting PLK1 in Non Small Cell Lung Cancer Cells

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

MicroRNA-100 Regulates Pancreatic Cancer Cells Growth and Sensitivity to Chemotherapy Through Targeting FGFR3.

MiR-654-3p Suppresses Non-Small Cell Lung Cancer Tumourigenesis by Inhibiting PLK4

MiR-100 Resensitizes Docetaxel-Resistant Human Lung Adenocarcinoma Cells (SPC-A1) to Docetaxel by Targeting Plk1

MicroRNA-1976 Functions As a Tumor Suppressor and Serves As a Prognostic Indicator in Non-Small Cell Lung Cancer by Directly Targeting PLCE1.

MiR-486-5p Serves As a Good Biomarker in Nonsmall Cell Lung Cancer and Suppresses Cell Growth with the Involvement of a Target PIK3R1

Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential.

Overexpression of Mir-100 Inhibits Cancer Growth, Migration, and Chemosensitivity in Human NSCLC Cells Through Fibroblast Growth Factor Receptor 3

MiR-509-3-5p Causes Aberrant Mitosis and Anti-Proliferative Effect by Suppression of PLK1 in Human Lung Cancer A549 Cells

MicroRNA-383 is a Tumor Suppressor and Potential Prognostic Biomarker in Human Non-Small Cell Lung Caner.

Potential role of miR-100 in cancer diagnosis, prognosis, and therapy

MicroRNA-125a-3p Downregulation Correlates with Tumorigenesis and Poor Prognosis in Patients with Non-Small Cell Lung Cancer

Potential Use of Microrna-200C As a Prognostic Marker in Non-Small Cell Lung Cancer.

Reduced Expression of Microrna-100 Confers Unfavorable Prognosis in Patients with Bladder Cancer

Microrna-99A is Downregulated and Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer A549 and H1299 Cells.

MiR-501-3p Functions As a Tumor Suppressor in Non-Small Cell Lung Cancer by Downregulating RAP1A